SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-14-006217
Filing Date
2014-11-12
Accepted
2014-11-12 17:15:04
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1402085_10q.htm 10-Q 638204
2 EXHIBIT 31.1 t1402085_ex31-1.htm EX-31.1 9773
3 EXHIBIT 31.2 t1402085_ex31-2.htm EX-31.2 9810
4 EXHIBIT 32.1 t1402085_ex32-1.htm EX-32.1 4002
5 EXHIBIT 32.2 t1402085_ex32-2.htm EX-32.2 4167
  Complete submission text file 0001571049-14-006217.txt   4870732

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cycc-20140930.xml EX-101.INS 644138
7 XBRL SCHEMA FILE cycc-20140930.xsd EX-101.SCH 45299
8 XBRL CALCULATION FILE cycc-20140930_cal.xml EX-101.CAL 44885
9 XBRL DEFINITION FILE cycc-20140930_def.xml EX-101.DEF 160533
10 XBRL LABEL FILE cycc-20140930_lab.xml EX-101.LAB 413928
11 XBRL PRESENTATION FILE cycc-20140930_pre.xml EX-101.PRE 282070
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 141215073
SIC: 2834 Pharmaceutical Preparations